BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 31278212)

  • 1. Cardiovascular Disease Risk Assessment: Triglyceride/High-Density Lipoprotein versus Metabolic Syndrome Criteria.
    Gharipour M; Sadeghi M; Nezafati P; Dianatkhah M; Sarrafzadegan N
    J Res Health Sci; 2019 May; 19(2):e00442. PubMed ID: 31278212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
    Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
    J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the Plasma Concentration Ratio of Triglyceride/High-Density Lipoprotein Cholesterol Identify Individuals at High Risk of Cardiovascular Disease During 40-Year Follow-Up?
    Lind L; Ingelsson E; Ärnlöv J; Sundström J; Zethelius B; Reaven GM
    Metab Syndr Relat Disord; 2018 Oct; 16(8):433-439. PubMed ID: 30183521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between European and Iranian cutoff points of triglyceride/high-density lipoprotein cholesterol concentrations in predicting cardiovascular disease outcomes.
    Gharipour M; Sadeghi M; Dianatkhah M; Nezafati P; Talaie M; Oveisgharan S; Golshahi J
    J Clin Lipidol; 2016; 10(1):143-9. PubMed ID: 26892131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men.
    Hadaegh F; Khalili D; Ghasemi A; Tohidi M; Sheikholeslami F; Azizi F
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):401-8. PubMed ID: 19091534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of the plasma concentration ratio of triglyceride/high-density lipoprotein cholesterol to identify increased cardio-metabolic risk in an east Asian population.
    Sung KC; Reaven G; Kim S
    Diabetes Res Clin Pract; 2014 Jul; 105(1):96-101. PubMed ID: 24842244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the plasma triglyceride/high-density lipoprotein cholesterol ratio to identify cardiovascular disease in hypertensive subjects.
    Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; Leiva Sisnieguez BC; March CE; Stavile RN; Balbín E; Reaven GM
    J Am Soc Hypertens; 2014 Oct; 8(10):724-31. PubMed ID: 25418494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Lipid Ratios to Identify Metabolic Syndrome.
    Rezapour M; Shahesmaeili A; Hossinzadeh A; Zahedi R; Najafipour H; Gozashti MH
    Arch Iran Med; 2018 Dec; 21(12):572-577. PubMed ID: 30634854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the triglyceride/high-density lipoprotein cholesterol ratio to identify cardiometabolic risk: impact of obesity?
    Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Marillet AG; Leiva Sisnieguez CE; Leiva Sisnieguez BC; Stavile RN; March CE; Reaven GM
    J Investig Med; 2017 Feb; 65(2):323-327. PubMed ID: 27638846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of cardiometabolic risk: visceral adiposity index versus triglyceride/HDL cholesterol ratio.
    Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Maciel PM; Reaven GM
    Am J Med; 2014 Feb; 127(2):152-7. PubMed ID: 24462013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes).
    Guyton JR; Slee AE; Anderson T; Fleg JL; Goldberg RB; Kashyap ML; Marcovina SM; Nash SD; O'Brien KD; Weintraub WS; Xu P; Zhao XQ; Boden WE
    J Am Coll Cardiol; 2013 Oct; 62(17):1580-4. PubMed ID: 23916935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
    Tehrani DM; Zhao Y; Blaha MJ; Mora S; Mackey RH; Michos ED; Budoff MJ; Cromwell W; Otvos JD; Rosenblit PD; Wong ND
    Am J Cardiol; 2016 Jun; 117(12):1921-7. PubMed ID: 27156827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal cutoff of the triglyceride to high-density lipoprotein cholesterol  ratio to detect cardiovascular risk factors among Han adults in Xinjiang.
    Li HY; Chen BD; Ma YT; Yang YN; Ma X; Liu F; Fu ZY; Xie X; Li XM; Pan S; He CH; Zheng YY; Wu Y; Tao J; Dong CL; Wu TT
    J Health Popul Nutr; 2016 Sep; 35(1):30. PubMed ID: 27586369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two surrogate estimates of insulin resistance to predict cardiovascular disease in apparently healthy individuals.
    Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Dulbecco CA; Reaven GM
    Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):366-373. PubMed ID: 28254109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study.
    Andersson C; Lyass A; Vasan RS; Massaro JM; D'Agostino RB; Robins SJ
    Am Heart J; 2014 Dec; 168(6):878-83.e1. PubMed ID: 25458651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) index as a reference criterion of risk for metabolic syndrome (MetS) and low insulin sensitivity in apparently healthy subjects.
    Baez-Duarte BG; Zamora-Gínez I; González-Duarte R; Torres-Rasgado E; Ruiz-Vivanco G; Pérez-Fuentes R; Celis TMRGOD
    Gac Med Mex; 2017; 153(2):152-158. PubMed ID: 28474700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the abilities of the plasma triglyceride/high-density lipoprotein cholesterol ratio and the metabolic syndrome to identify insulin resistance.
    Salazar MR; Carbajal HA; Espeche WG; Leiva Sisnieguez CE; March CE; Balbín E; Dulbecco CA; Aizpurúa M; Marillet AG; Reaven GM
    Diab Vasc Dis Res; 2013 Jul; 10(4):346-52. PubMed ID: 23624761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations Between the Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Metabolic Syndrome, Insulin Resistance, and Lifestyle Habits in Healthy Japanese.
    Moriyama K
    Metab Syndr Relat Disord; 2020 Jun; 18(5):260-266. PubMed ID: 32191558
    [No Abstract]   [Full Text] [Related]  

  • 19. Are non-high-density lipoprotein fractions associated with pediatric metabolic syndrome? The CASPIAN-V study.
    Angoorani P; Khademian M; Ejtahed HS; Heshmat R; Motlagh ME; Vafaeenia M; Shafiee G; Mahdivi-Gorabi A; Qorbani M; Kelishadi R
    Lipids Health Dis; 2018 Nov; 17(1):257. PubMed ID: 30428934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study.
    Lee JS; Chang PY; Zhang Y; Kizer JR; Best LG; Howard BV
    Diabetes Care; 2017 Apr; 40(4):529-537. PubMed ID: 28122840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.